In this Q and A, Valentina Celoria, MD, discusses the relationship between the human microbiome and psoriatic disease, as well as what this relationship may mean for future treatments.
Consultant360 spoke with Zenas Yiu, MBChB, PhD, NIHR Clinical Lecturer in Dermatology at the University of Manchester, about a recent study examining the relationship between psoriasis and risk of serious...
Adam Ford, BS, and April Armstrong, MD, MPH, answer our questions about the role of diet in psoriatic disease and the importance of dietary recommendations for individuals with psoriasis and/or psoriatic...
Lihi Eder, MD, PhD, answers our questions about her research into whether a multiple single-nucleotide polymorphism genetic test can predict a diagnosis of PsA in patients with psoriasis with...
A recent study that was awarded an honorable mention at the 2018 AAD Annual Meeting identified numerous healthcare and demographic disparities in hospital readmissions for skin disease. We spoke with lead...
Joel Gelfand, MD, MSCE, from the University of Pennsylvania's Perelman School of Medicine, discusses his research on the interaction between psoriasis medication and cardiovascular disease.
The Dermatologist spoke with Joel M. Gelfand, MD, MSCE, professor of dermatology and epidemiology, Perelman School of Medicine, University of Pennsylvania
